1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Lungs in Vitro Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 2D Cell Models
  • 1.2.3 3D Cell Models
  • 1.2.4 Commercial 3D Cell Models
  • 1.2.5 Inhouse 3D Cell Models
• 1.3 Market by Application
  • 1.3.1 Global Lungs in Vitro Market Share by Application: 2020 VS 2026
  • 1.3.2 Drug Screening
  • 1.3.3 Toxicology
  • 1.3.4 3D Model Development
  • 1.3.5 Basic Research
  • 1.3.6 Physiologic Research
  • 1.3.7 Stem Cell Research
  • 1.3.8 Regenerative Medicine
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Lungs in Vitro Market Perspective (2015-2026)
• 2.2 Global Lungs in Vitro Growth Trends by Regions
  • 2.2.1 Lungs in Vitro Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Lungs in Vitro Historic Market Share by Regions (2015-2020)
  • 2.2.3 Lungs in Vitro Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Lungs in Vitro Players by Market Size
  • 3.1.1 Global Top Lungs in Vitro Players by Revenue (2015-2020)
  • 3.1.2 Global Lungs in Vitro Revenue Market Share by Players (2015-2020)
• 3.2 Global Lungs in Vitro Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Lungs in Vitro Revenue
• 3.4 Global Lungs in Vitro Market Concentration Ratio
  • 3.4.1 Global Lungs in Vitro Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Lungs in Vitro Revenue in 2019
• 3.5 Key Players Lungs in Vitro Area Served
• 3.6 Key Players Lungs in Vitro Product Solution and Service
• 3.7 Date of Enter into Lungs in Vitro Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Lungs in Vitro Breakdown Data by Type (2015-2026)

• 4.1 Global Lungs in Vitro Historic Market Size by Type (2015-2020)
• 4.2 Global Lungs in Vitro Forecasted Market Size by Type (2021-2026)

5 Lungs in Vitro Breakdown Data by Application (2015-2026)

• 5.1 Global Lungs in Vitro Historic Market Size by Application (2015-2020)
• 5.2 Global Lungs in Vitro Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Lungs in Vitro Market Size (2015-2026)
• 6.2 North America Lungs in Vitro Market Size by Type (2015-2020)
• 6.3 North America Lungs in Vitro Market Size by Application (2015-2020)
• 6.4 North America Lungs in Vitro Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Lungs in Vitro Market Size (2015-2026)
• 7.2 Europe Lungs in Vitro Market Size by Type (2015-2020)
• 7.3 Europe Lungs in Vitro Market Size by Application (2015-2020)
• 7.4 Europe Lungs in Vitro Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Lungs in Vitro Market Size (2015-2026)
• 8.2 China Lungs in Vitro Market Size by Type (2015-2020)
• 8.3 China Lungs in Vitro Market Size by Application (2015-2020)
• 8.4 China Lungs in Vitro Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Lungs in Vitro Market Size (2015-2026)
• 9.2 Japan Lungs in Vitro Market Size by Type (2015-2020)
• 9.3 Japan Lungs in Vitro Market Size by Application (2015-2020)
• 9.4 Japan Lungs in Vitro Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Lungs in Vitro Market Size (2015-2026)
• 10.2 Southeast Asia Lungs in Vitro Market Size by Type (2015-2020)
• 10.3 Southeast Asia Lungs in Vitro Market Size by Application (2015-2020)
• 10.4 Southeast Asia Lungs in Vitro Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 ATCC
  • 11.1.1 ATCC Company Details
  • 11.1.2 ATCC Business Overview
  • 11.1.3 ATCC Lungs in Vitro Introduction
  • 11.1.4 ATCC Revenue in Lungs in Vitro Business (2015-2020))
  • 11.1.5 ATCC Recent Development
• 11.2 Lonza
  • 11.2.1 Lonza Company Details
  • 11.2.2 Lonza Business Overview
  • 11.2.3 Lonza Lungs in Vitro Introduction
  • 11.2.4 Lonza Revenue in Lungs in Vitro Business (2015-2020)
  • 11.2.5 Lonza Recent Development
• 11.3 Epithelix
  • 11.3.1 Epithelix Company Details
  • 11.3.2 Epithelix Business Overview
  • 11.3.3 Epithelix Lungs in Vitro Introduction
  • 11.3.4 Epithelix Revenue in Lungs in Vitro Business (2015-2020)
  • 11.3.5 Epithelix Recent Development
• 11.4 Mattek
  • 11.4.1 Mattek Company Details
  • 11.4.2 Mattek Business Overview
  • 11.4.3 Mattek Lungs in Vitro Introduction
  • 11.4.4 Mattek Revenue in Lungs in Vitro Business (2015-2020)
  • 11.4.5 Mattek Recent Development
• 11.5 Emulate
  • 11.5.1 Emulate Company Details
  • 11.5.2 Emulate Business Overview
  • 11.5.3 Emulate Lungs in Vitro Introduction
  • 11.5.4 Emulate Revenue in Lungs in Vitro Business (2015-2020)
  • 11.5.5 Emulate Recent Development
• 11.6 Mimetas
  • 11.6.1 Mimetas Company Details
  • 11.6.2 Mimetas Business Overview
  • 11.6.3 Mimetas Lungs in Vitro Introduction
  • 11.6.4 Mimetas Revenue in Lungs in Vitro Business (2015-2020)
  • 11.6.5 Mimetas Recent Development
• 11.7 Tissuse
  • 11.7.1 Tissuse Company Details
  • 11.7.2 Tissuse Business Overview
  • 11.7.3 Tissuse Lungs in Vitro Introduction
  • 11.7.4 Tissuse Revenue in Lungs in Vitro Business (2015-2020)
  • 11.7.5 Tissuse Recent Development
• 11.8 Insphero
  • 11.8.1 Insphero Company Details
  • 11.8.2 Insphero Business Overview
  • 11.8.3 Insphero Lungs in Vitro Introduction
  • 11.8.4 Insphero Revenue in Lungs in Vitro Business (2015-2020)
  • 11.8.5 Insphero Recent Development
• 11.9 Cn Bio
  • 11.9.1 Cn Bio Company Details
  • 11.9.2 Cn Bio Business Overview
  • 11.9.3 Cn Bio Lungs in Vitro Introduction
  • 11.9.4 Cn Bio Revenue in Lungs in Vitro Business (2015-2020)
  • 11.9.5 Cn Bio Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Lungs in Vitro Scope and Market Size
Lungs in Vitro market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Lungs in Vitro market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
2D Cell Models
3D Cell Models
Commercial 3D Cell Models
Inhouse 3D Cell Models

Market segment by Application, split into
Drug Screening
Toxicology
3D Model Development
Basic Research
Physiologic Research
Stem Cell Research
Regenerative Medicine

Based on regional and country-level analysis, the Lungs in Vitro market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Lungs in Vitro market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
ATCC
Lonza
Epithelix
Mattek
Emulate
Mimetas
Tissuse
Insphero
Cn Bio